Sorilla Prey-Mary
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Eosinophilic fasciitis induced by checkpoint inhibitors: A retrospective multicenter case series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.
Journal: Journal of the American Academy of Dermatology
Published: March 21, 2026
Management of cardiac metastases of melanoma in the era of immunotherapy: a case series.
Journal: Melanoma research
Published: March 25, 2025
Diagnosis and management of infantile hemangiomas: Tremendous advances over the last 15 years.
Journal: Presse medicale (Paris, France : 1983)
Published: January 03, 2025
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study.
Journal: The Lancet. Oncology
Published: October 23, 2024
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 05, 2024
Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma.
Journal: The oncologist
Published: September 20, 2023
Use of spironolactone for the treatment of acne in adolescent girls.
Journal: Annales de dermatologie et de venereologie
Published: August 23, 2023
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns.
Journal: Annales de dermatologie et de venereologie
Published: February 07, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026